Charles River Laboratories - 25 Year Stock Price History | CRL

Historical daily share price chart and data for Charles River Laboratories since 2000 adjusted for splits and dividends. The latest closing stock price for Charles River Laboratories as of July 02, 2025 is 157.49.
  • The all-time high Charles River Laboratories stock closing price was 458.30 on September 24, 2021.
  • The Charles River Laboratories 52-week high stock price is 254.15, which is 61.4% above the current share price.
  • The Charles River Laboratories 52-week low stock price is 91.86, which is 41.7% below the current share price.
  • The average Charles River Laboratories stock price for the last 52 weeks is 175.35.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Charles River Laboratories Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2025 150.3165 182.6400 190.1400 99.7500 157.4900 -14.69%
2024 216.1551 234.2500 273.4300 178.5800 184.6000 -21.91%
2023 206.8410 218.4000 259.9200 164.5200 236.4000 8.49%
2022 246.3805 362.1100 362.1100 182.4400 217.9000 -42.17%
2021 354.9112 249.6700 458.3000 249.6700 376.7800 50.80%
2020 189.2381 153.8900 252.6200 98.9000 249.8600 63.56%
2019 134.9265 111.0900 152.7600 104.8200 152.7600 34.97%
2018 116.1663 110.6500 137.2300 98.1900 113.1800 3.41%
2017 97.1831 76.5300 118.0900 76.5300 109.4500 43.65%
2016 79.1136 78.2500 88.4400 67.1000 76.1900 -5.22%
2015 72.9128 63.8800 84.2000 61.5900 80.3900 26.32%
2014 58.2804 52.8800 65.5900 50.7400 63.6400 19.98%
2013 45.2635 38.0400 53.3600 38.0400 53.0400 41.55%
2012 35.7702 27.7500 41.2400 27.3900 37.4700 37.10%
2011 35.2187 35.8400 42.4700 25.9500 27.3300 -23.10%
2010 34.3705 33.5700 41.5600 28.2500 35.5400 5.49%
2009 31.0983 26.8900 40.0900 23.1500 33.6900 28.59%
2008 54.5137 65.1800 68.8200 20.7800 26.2000 -60.18%
2007 52.4677 43.2400 67.3500 43.2400 65.8000 52.14%
2006 42.8401 42.6600 50.5600 33.9200 43.2500 2.08%
2005 46.7138 45.3500 52.7100 41.7600 42.3700 -7.91%
2004 44.1685 34.0400 48.8700 33.7700 46.0100 34.02%
2003 31.1122 38.5500 38.5500 24.7500 34.3300 -10.78%
2002 34.7652 32.4900 40.9800 27.8000 38.4800 14.93%
2001 29.3127 26.1250 37.4000 18.0000 33.4800 22.30%
Sector Industry Market Cap Revenue
Medical Medical Services $7.735B $4.050B
Charles River Laboratories International, Inc. is a full service, early-stage contract research organization. The company provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions globally accelerate their research and drug development efforts. The company has a diverse portfolio of discovery and safety assessment services, both Good Laboratory Practice (GLP) and non-GLP. This helps support its clients from target identification through non-clinical development. Charles River also provides a line of products and services to support clients' manufacturing activities. Utilizing the company's broad portfolio of products and services, clients can create a more flexible drug development model, aiming cost reduction, productivity enhancement and increase in speed to market. Charles River currently has three reporting segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA) and Manufacturing Support.
Stock Name Country Market Cap PE Ratio
Danaher (DHR) United States $144.923B 27.18
CVS Health (CVS) United States $84.250B 10.47
Elevance Health (ELV) United States $79.134B 10.21
Cencora (COR) United States $56.436B 19.63
DiDi Global (DIDIY) China $22.826B 24.25
Natera (NTRA) United States $22.062B 0.00
Labcorp Holdings (LH) United States $21.762B 17.65
BioMerieux (BMXMF) France $16.861B 0.00
EUROFINS SCIENT (ERFSF) Luxembourg $13.704B 0.00
Solventum (SOLV) United States $13.538B 14.33
CochLear (CHEOY) Australia $12.960B 0.00
ICON (ICLR) Ireland $12.180B 11.32
Revvity (RVTY) United States $11.893B 20.47
Viatris (VTRS) United States $10.962B 3.77
Avantor (AVTR) United States $9.465B 13.75
Medpace Holdings (MEDP) United States $9.371B 24.89
HealthEquity (HQY) United States $8.758B 38.36
Sonic Healthcare (SKHHY) Australia $8.535B 0.00
Caris Life Sciences,�Inc (CAI) United States $6.798B 0.00
Amplifon S.p.A (AMFPF) Italy $5.378B 29.44
Bausch + Lomb (BLCO) Canada $4.867B 28.67
BrightSpring Health Services (BTSG) United States $3.868B 35.48
Sotera Health (SHC) United States $3.304B 18.77
Surgery Partners (SGRY) United States $2.822B 36.70
Alignment Healthcare (ALHC) United States $2.693B 0.00
Concentras Parent (CON) United States $2.647B 15.30
Organon (OGN) United States $2.639B 2.80
GeneDx Holdings (WGS) United States $2.562B 98.67
PACS (PACS) United States $1.987B 0.00
Ardent Health (ARDT) United States $1.920B 8.18
Progyny (PGNY) United States $1.821B 40.08
GoodRx Holdings (GDRX) United States $1.805B 36.11
Premier (PINC) United States $1.789B 13.58
Teladoc Health (TDOC) United States $1.465B 0.00
Establishment Labs Holdings (ESTA) $1.283B 0.00
Pediatrix Medical (MD) United States $1.184B 9.01
CareDx (CDNA) United States $1.085B 16.95
Agilon Health (AGL) United States $0.989B 0.00
Ryman Healthcare (RYHTY) New Zealand $0.919B 0.00
AMN Healthcare Services Inc (AMN) United States $0.843B 7.89
QDM (QDMI) Hong Kong, SAR China $0.729B 0.00
Nutex Health (NUTX) United States $0.679B 10.28
Embecta (EMBC) United States $0.599B 4.04
LifeMD (LFMD) United States $0.588B 0.00
InnovAge Holding (INNV) United States $0.560B 0.00
Sonida Senior Living (SNDA) United States $0.470B 0.00
Auna S.A (AUNA) Luxembourg $0.467B 10.52
Omada Health (OMDA) $0.466B 0.00
SBC Medicals (SBC) United States $0.463B 0.00
Enhabit (EHAB) United States $0.390B 32.12
So-Young (SY) China $0.338B 0.00
Performant Healthcare (PHLT) United States $0.326B 0.00
COMPASS Pathways (CMPS) United Kingdom $0.316B 0.00
Beauty Health (SKIN) United States $0.266B 0.00
Oncology Institute (TOI) United States $0.218B 0.00
DocGo (DCGO) United States $0.160B 26.17
Pheton Holdings (PTHL) China $0.121B 0.00
Sera Prognostics (SERA) United States $0.092B 0.00
KindlyMD (NAKA) United States $0.079B 0.00
Ascend Wellness Holdings (AAWH) United States $0.070B 0.00
NeueHealth (NEUE) United States $0.061B 0.00
IceCure Medical (ICCM) Israel $0.056B 0.00
ModivCare (MODV) United States $0.045B 0.00
Biodesix (BDSX) United States $0.040B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.034B 0.00
Basel Medical Group (BMGL) Singapore $0.032B 0.00
OSR Holdings (OSRH) United States $0.027B 0.00
Intelligent Bio Solutions (INBS) United States $0.013B 0.00
BioNexus Gene Lab (BGLC) $0.012B 0.00
Co-Diagnostics (CODX) United States $0.010B 0.00
SeaStar Medical Holding (ICU) United States $0.006B 0.00
XWELL (XWEL) United States $0.005B 0.00
Aclarion (ACON) United States $0.004B 0.00
NewGenIvf Group (NIVF) Thailand $0.004B 0.00
ISpecimen (ISPC) United States $0.003B 0.00
INVO Fertility (IVF) United States $0.002B 0.00
Cano Health (CANOQ) United States $0.000B 0.00